Literature DB >> 15810915

Mutation analysis in 51 patients with haemophilia A: report of 10 novel mutations and correlations between genotype and clinical phenotype.

M Hill1, S Deam, B Gordon, G Dolan.   

Abstract

We report the results of genetic analysis on a series of 51 patients attending this Haemophilia Comprehensive Care Centre. The most common cause of severe haemophilia A--the factor VIII intron 22 inversion was detected in eight families and the factor VIII intron 1 inversion in three families. Mutation analysis was carried out on the remaining patients by nucleotide sequencing of genomic DNA after screening with conformation-sensitive gel electrophoresis (CSGE) or denaturing high-performance liquid chromatography (dHPLC). A total of 27 different FVIII non-inversion mutations were detected. Severe haemophilia was associated with 12 null mutations (six nonsense, six frameshift) and four missense mutations. A further 11 different missense mutations were associated with moderate or mild disease. To our knowledge, six null mutations [1950del 4(tttg), 3270-75insA, 4416del 10, 6735-38delA, W1029X, Y1792X] and four missense mutations (E1682K, M1947V, P2048L, P2143L) have not been previously published. Each novel missense mutation occurred at a highly conserved residue, no other candidate mutation was detected on screening the entire coding region of the FVIII gene and they were not detected in a screen of individuals without haemophilia A. The genotype-phenotype correlations of the FVIII mutations detected will be discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15810915     DOI: 10.1111/j.1365-2516.2005.01069.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  7 in total

1.  Severe Hemophilia A in a Male Old English Sheep Dog with a C→T Transition that Created a Premature Stop Codon in Factor VIII.

Authors:  Jay N Lozier; Mark T Kloos; Elizabeth P Merricks; Nathaly Lemoine; Margaret H Whitford; Robin A Raymer; Dwight A Bellinger; Timothy C Nichols
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

2.  Factor VIII Intron 22 Inversion in Severe Hemophilia A Patients in Palestine.

Authors:  Caesar Mahmoud Abu Arra; Fekri Samarah; Nael Sudqi Abu Hasan
Journal:  Scientifica (Cairo)       Date:  2020-09-25

3.  Method validation and clinical utility of chromogenic factor VIII assay compared to one-stage assay.

Authors:  Wilmare Gouws; Elsabie Botha; Adele Visser
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

4.  In silico profiling of deleterious amino acid substitutions of potential pathological importance in haemophlia A and haemophlia B.

Authors:  George Priya Doss C
Journal:  J Biomed Sci       Date:  2012-03-16       Impact factor: 8.410

5.  Clustered F8 missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activity.

Authors:  Irving Donadon; John H McVey; Isabella Garagiola; Alessio Branchini; Mimosa Mortarino; Flora Peyvandi; Francesco Bernardi; Mirko Pinotti
Journal:  Haematologica       Date:  2017-11-23       Impact factor: 9.941

6.  Identification of the Intron 22 and Intron 1 Inversions of the Factor VIII Gene in Iraqi Kurdish Patients With Hemophilia A.

Authors:  Aveen M Raouf Abdulqader; Ali Ibrahim Mohammed; Shwan Rachid; Peyman Ghoraishizadeh; Sarwar Noori Mahmood
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

7.  Frequency of Intron 22 Inversion in Severe Hemophilia A Patients.

Authors:  Javeria Ashfaq; Rehana Ahmed; Faryal Tariq; Qurat Ul Abedin; Madiha Abid; Munira Borhany
Journal:  Cureus       Date:  2022-08-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.